Contact
A direct line to the office.
For advisory engagements, board counsel, speaking, and confidential inquiries.
Mission
To expose commercialization failure for what it actually is — an access infrastructure failure in disguise — and to counsel leadership teams on the architecture that eliminates that disguise before launch.
Vision
A generation of biopharmaceutical leaders who compete on continuity, not on functional excellence in isolation — and who treat patient movement as the truest signal of commercialization success.
Private Briefing
Schedule a Strategic Access Briefing
For commercialization strategy, patient access infrastructure, launch readiness, reimbursement architecture, and executive advisory discussions.